Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 200ug (plus a 9% manufacturing overage); levothyroxine sodium 200ug (plus a 2% manufacturing overage) - tablet - 200 mcg - active: levothyroxine sodium 200ug (plus a 9% manufacturing overage) excipient: acacia allura red ac lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 200ug (plus a 2% manufacturing overage) excipient: acacia allura red ac lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 25ug (plus a 5% manufacturing overage); levothyroxine sodium 25ug (plus a 9% manufacturing overage); levothyroxine sodium 25ug (plus a 4% manufacturing overage) - tablet - 25 mcg - active: levothyroxine sodium 25ug (plus a 5% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose sunset yellow aluminium lake active: levothyroxine sodium 25ug (plus a 9% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose sunset yellow aluminium lake active: levothyroxine sodium 25ug (plus a 4% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose sunset yellow aluminium lake - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 300ug (plus a 9% manufacturing overage); levothyroxine sodium 300ug (plus a 2% manufacturing overage) - tablet - 300 mcg - active: levothyroxine sodium 300ug (plus a 9% manufacturing overage) excipient: acacia brilliant blue fcf lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose sunset yellow aluminium lake active: levothyroxine sodium 300ug (plus a 2% manufacturing overage) excipient: acacia brilliant blue fcf lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose sunset yellow aluminium lake - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 50ug (plus a 3% manufacturing overage); levothyroxine sodium 50ug (plus a 9% manufacturing overage) - tablet - 50 mcg - active: levothyroxine sodium 50ug (plus a 3% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 50ug (plus a 9% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 75ug (plus a 3% manufacturing overage); levothyroxine sodium 75ug (plus a 9% manufacturing overage) - tablet - 75 mcg - active: levothyroxine sodium 75ug (plus a 3% manufacturing overage) excipient: acacia allura red ac indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 75ug (plus a 9% manufacturing overage) excipient: acacia allura red ac indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

viatris limited - levothyroxine sodium 88ug (plus a 3% manufacturing overage); levothyroxine sodium 88ug (plus a 9% manufacturing overage) - tablet - 88 mcg - active: levothyroxine sodium 88ug (plus a 3% manufacturing overage) excipient: acacia d&c olive lake blend lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose active: levothyroxine sodium 88ug (plus a 9% manufacturing overage) excipient: acacia d&c olive lake blend lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.

USA - engelska - NLM (National Library of Medicine)

rebel distributors corp. - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves' disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option. - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole. propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

USA - engelska - NLM (National Library of Medicine)

actavis pharma, inc. - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil tablets are indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

USA - engelska - NLM (National Library of Medicine)

par pharmaceutical, inc. - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

USA - engelska - NLM (National Library of Medicine)

american health packaging - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.